Psoriasis and Ischemic Coronary Artery Disease

Autor: Mahiques-Santos, L., Soriano-Navarro, C.J., Perez-Pastor, G., Tomas-Cabedo, G., Pitarch-Bort, G., Valcuende-Cavero, F.

Publikováno v: In Actas Dermo-Sifiliográficas (English Edition) March 2015 106(2):112-116

Strategic Plan for the Spanish Academy of Dermatology and Venerology (AEDV): FuturAEDV 2013-2017

Autor: Ribera Pibernat, M., Moreno Jiménez, J.C., Valcuende Cavero, F., Soto de Delás, J., Vázquez Veiga, H., Lázaro Ochaíta, P., Giménez Arnau, A.

Publikováno v: In Actas Dermo-Sifiliográficas (English Edition) September 2014 105(7):639-654

Informed Consent in Dermatology: An Update

Autor: Valcuende Cavero, F., Iglesias Valcuende, M., Diaz Diaz, R.M.

Publikováno v: In Actas Dermo-Sifiliográficas (English Edition) July-August 2014 105(6):569-573

Improved effectiveness from individualized dosing of self-administered biologics for the treatment of moderate-to-severe psoriasis: a 5-year retrospective chart review from a Spanish University Hospital

Autor: Sanz-Gil R, Pellicer A, Montesinos MC, Valcuende-Cavero F

Publikováno v: JOURNAL OF DERMATOLOGICAL TREATMENT
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Background: Biologics for moderate-to-severe psoriasis are expensive and treatment substitutions may vastly increase cost. Moreover, administration regimens in routine practice may differ from recommended guidelines. Objectives: To evaluate long-term

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::42df27326c9bdd78fe7a20417ac0d6d3
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=6982

Report of two cases of Behcet's disease developed during treatment with secukinumab

Autor: Barrado-Solis N, Rodrigo-Nicolas B, De la Morena-Barrio I, Perez-Pastor G, Sanchis-Sanchez C, Tomas-Cabedo G, Valcuende-Cavero F

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

Secukinumab is a fully human anti-interleukin 17A monoclonal antibody widely used for moderate to severe psoriasis, with great efficiency and very infrequent adverse events. Nevertheless, we present two cases of Behcet Disease (BD) developed a few we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::65f8a767e72802e19feefcbc0ffb7b7d
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4496